Uptravi® (Selexipag) for Pulmonary Hypertension Uptravi® (selexipag) is an oral IP prostacyclin receptor agonist marketed by Actelion Pharmaceuticals US, Inc., which was approved by the US FDA for the treatment of pulmonary arterial hypertension in December 2015. Posted 01/29/2016.
We thank AT&T Employee Giving Campaign for their comprehensive donation to tackle scleroderma! There's no better or more cost effective way to tackle scleroderma than through the nonprofit ISN at sclero.org. 01/26/2016. (Also see Donate)
We heartily thank Arnold Slotkin for his donation to tackle scleroderma, in loving memory of Marta Marx. Posted 01/23/2016.
The International Scleroderma Network thanks Genentech for their sponsorship support! Posted 01/21/2016.
The International Scleroderma Network thanks Gilead for their sponsorship support! Posted 01/14/2016.
Would you like to help scientists find a cure for scleroderma? Dozens of clinical trials for scleroderma and pulmonary hypertension are actively recruiting now. Review them and be sure to ask your scleroderma expert about the ones you are interested in. (Also see Current Clinical Trials and Scleroderma Experts) Posted 01/09/2016.
Did you know you can help raise scleroderma awareness? The nonprofit International Scleroderma Network offers scleroderma awareness bracelets! Bracelets for just $2.50 each with free shipping and handling! They say "scleroderma" on one side and "sclero.org" on the other. (Also see Get Scleroderma Awareness Bracelets) Posted 01/07/2016.
The International Scleroderma Network thanks United Therapeutics for their sponsorship support! Posted 01/06/2016.
Shop at AmazonSmile and Amazon will make a donation to the nonprofit International Scleroderma Network! Posted 01/04/2016.
The International Scleroderma Network thanks Actelion Pharmaceuticals US, Inc. for their sponsorship support! Posted 01/02/2016.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: